Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Tokushukai Medical Corporation has a patent portfolio in the Biotechnology & Pharmaceuticals technology area. There is 1 pending office action currently active. This action is assigned to 1 distinct examiner, RAHMAN, MASUDUR, and is located within 1 distinct art unit. The 1 pending office action represents the company's current focus in the Biotechnology & Pharmaceuticals sector.
RAHMAN, MASUDUR is the busiest examiner for this portfolio, managing 1 pending office action. Because there is only 1 distinct examiner, the prosecution is focused entirely on this individual's review. The presence of 1 distinct art unit further emphasizes the targeted nature of the company's current pending applications.
Practitioners should note that the 1 distinct examiner handles the entire pending workload, allowing for a consistent prosecution path. With 1 distinct art unit involved, the company's intellectual property efforts are concentrated in a specific technical field. This 1 pending office action serves as the sole active matter for the company within the Biotechnology & Pharmaceuticals technology area.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RAHMAN, MASUDUR | 1 | 72.9% | +31.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18560266 | COMPOSITION AND USE THEREOF | RAHMAN, MASUDUR | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18560266 | COMPOSITION AND USE THEREOF | RAHMAN, MASUDUR | — |
| Art Unit | Apps |
|---|---|
| 1633 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18560266 | COMPOSITION AND USE THEREOF | RAHMAN, MASUDUR | 1633 | §102§103§112 | Non-Final OA | — | Pending | Nov 10, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialTokushukai Medical Corporation has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Masudur Rahman has the most, with 1 of Tokushukai Medical Corporation's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
